PH30414A - Thymosin alpha-1 derivatives - Google Patents

Thymosin alpha-1 derivatives

Info

Publication number
PH30414A
PH30414A PH47697A PH47697A PH30414A PH 30414 A PH30414 A PH 30414A PH 47697 A PH47697 A PH 47697A PH 47697 A PH47697 A PH 47697A PH 30414 A PH30414 A PH 30414A
Authority
PH
Philippines
Prior art keywords
derivatives
thymosin alpha
thymosin
alpha
Prior art date
Application number
PH47697A
Other languages
English (en)
Inventor
Su-Sun Wang
Original Assignee
Alpha 1 Biomedicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha 1 Biomedicals Inc filed Critical Alpha 1 Biomedicals Inc
Publication of PH30414A publication Critical patent/PH30414A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57581Thymosin; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH47697A 1993-02-03 1994-02-02 Thymosin alpha-1 derivatives PH30414A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1308793A 1993-02-03 1993-02-03

Publications (1)

Publication Number Publication Date
PH30414A true PH30414A (en) 1997-05-09

Family

ID=21758238

Family Applications (1)

Application Number Title Priority Date Filing Date
PH47697A PH30414A (en) 1993-02-03 1994-02-02 Thymosin alpha-1 derivatives

Country Status (7)

Country Link
US (1) US5512656A (es)
CN (2) CN1058500C (es)
AU (1) AU6235194A (es)
EC (1) ECSP941031A (es)
MY (1) MY111439A (es)
PH (1) PH30414A (es)
WO (1) WO1994018233A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers
WO2001096527A2 (en) * 2000-06-14 2001-12-20 Chanda Zaveri Peptides with physiological activity
BR0114642A (pt) * 2000-10-13 2004-01-20 Univ Monash Prevenção de doenças através da reativação do timo
WO2004048971A1 (en) * 2002-11-25 2004-06-10 Sciclone Pharmaceuticals, Inc. Methods of protecting against radiation damage using alpha thymosin
EP1613340B1 (en) 2003-03-28 2010-05-12 SciClone Pharmaceuticals, Inc. Treatment of aspergillus infections with thymosin alpha 1
KR20070119615A (ko) * 2005-01-14 2007-12-20 리지너크스 바이오 파마소티컬스, 인코포레이티드 개질된 베타 티모신 펩티드
ES2288118B1 (es) * 2006-05-10 2008-11-01 Bcn Peptides, S.A. Procedimiento para sintetizar timosinas.
WO2009151689A2 (en) 2008-03-17 2009-12-17 Regenerx Biopharmaceuticals, Inc. Improved beta thymosin fragments
CN102580059A (zh) * 2012-03-28 2012-07-18 厦门大学 胸腺素α原在制备预防和治疗肝癌药物中的应用
CN113135988B (zh) * 2021-04-08 2022-04-01 润辉生物技术(威海)有限公司 一种胸腺肽β4的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US447926A (en) * 1891-03-10 Process of obtaining bromine and iodine
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
CH641152A5 (en) * 1977-04-22 1984-02-15 Hoffmann La Roche Process for preparing thymosin alpha-1 and an analogue
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
DE3100974A1 (de) * 1980-01-18 1982-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente enthaltende arzneimittel mit immunregulierender wirkung, und thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente
US4293455A (en) * 1980-04-07 1981-10-06 Rockefeller University N.sup.α -Desacetylthymosinα1 and process
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
DE3137231A1 (de) * 1981-09-18 1983-04-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Bis-thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-verbindungen
US4855407A (en) * 1985-04-11 1989-08-08 Alpha-1 Biomedicals, Inc. Solid phase process for synthesizing peptides

Also Published As

Publication number Publication date
ECSP941031A (es) 1994-09-16
CN1058500C (zh) 2000-11-15
AU6235194A (en) 1994-08-29
CN1150208C (zh) 2004-05-19
US5512656A (en) 1996-04-30
MY111439A (en) 2000-05-31
CN1223266A (zh) 1999-07-21
WO1994018233A1 (en) 1994-08-18
CN1094411A (zh) 1994-11-02

Similar Documents

Publication Publication Date Title
IL122339A0 (en) Thiohydantoine derivatives
GR3029455T3 (en) 3-Aryl-4-hydroxy-3-dihydrofuranone derivatives.
HU9400724D0 (en) 2-thio-substituted carbapeneme derivatives
LTIP1874A (en) Substituted azolone derivatives
ZA945504B (en) Benzocarbocyclic derivatives
PH30414A (en) Thymosin alpha-1 derivatives
ZA947183B (en) 3-aryl-4-hydroxy-Delta3-dihydrofuranone derivatives
ZA946158B (en) Methyl 3-methoxy-2-phenyl-acrylates
ZA945589B (en) 2-phenylpyrrole derivatives
ZA947128B (en) Hydroxyethyl-azolyl derivatives
HU9402534D0 (en) New naphtoxazine derivatives
GB9319504D0 (en) Conveyors
ZA945588B (en) 2-Phenylpyrrole derivatives
GB2273642B (en) Preserves
GB9407248D0 (en) Conveyors
GB2274282B (en) Piperazine-and piperidine-isoxazole derivatives
GB9304440D0 (en) 2-acyloxycephem derivatives
GB9420074D0 (en) Urinal
IL110645A0 (en) Azoxycyanobenzodioxane derivatives
GB9311613D0 (en) Thienylthiazole derivatives
ZA941763B (en) Carpaine derivatives.
ZA945831B (en) Hydroisoquinoline derivatives
ZA944500B (en) 2-phenylpyrrole derivatives
GB9300854D0 (en) Benzofuranylimidazoline derivatives
IL108525A0 (en) Lyxofuranosyl derivatives